{
    "clinical_study": {
        "@rank": "56884", 
        "brief_summary": {
            "textblock": "Collection of data from different sites regardless of whether they use standard or tailored\n      protocols for the application of high concentration iodinated contrast agents to assess if\n      the individually patient-adapted protocols result in a similar diagnostic image quality."
        }, 
        "brief_title": "Multidetector Computed Tomography (MDCT) Tailored Protocol", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Patients Undergoing Contrast Enhanced Multidetector Computed Tomography of the Chest, Abdomen, Liver or Aorta for Any Diagnostic Cause", 
        "detailed_description": {
            "textblock": "To record technical information and compare image quality regarding routine MDCT procedures\n      with contrast administration using a tailored contrast injection and radiation dose\n      protocol. The hypotheses are that the tailored protocols lead to a lower applied mean\n      radiation dose compared to the use of standard protocols and will provide a more\n      standardized contrast dose per patient size without impairing diagnostic quality."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 18 years of age\n\n          -  Scheduled to undergo contrast enhanced MDCT of the abdomen, liver, aorta, or chest\n\n          -  Provides written informed consent\n\n        Exclusion Criteria:\n\n          -  Previously enrolled and completed the study\n\n          -  Known allergy to iodinated contrast media\n\n          -  Pregnancy or lactation\n\n          -  Clinically unsuitable for the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients undergoing MDCT of the abdomen, liver, chest or aorta and receiving high\n        iodinated contrast agents"
            }
        }, 
        "enrollment": {
            "#text": "1493", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01737333", 
            "org_study_id": "IOPM-101"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 27, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28203"
                    }, 
                    "name": "Department of Radiology Carolinas Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milan", 
                        "country": "Italy", 
                        "zip": "20162"
                    }, 
                    "name": "Oepedale Niguarda"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Italy"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "A Multicenter, Multinational, Randomized Study of Standard vs. Patient-Adapted Protocols in Multidetector Computed Tomography (MDCT) of the Chest, Abdomen, Liver or Aorta", 
        "overall_official": {
            "affiliation": "Bracco Diagnostics, Inc", 
            "last_name": "Martin Krix, M.D.", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Images are to be assessed according to the following scale: 0=Uninterpretable (Image quality severely affected by motion artifacts or technical reasons; need to repeat the examination); 1=Insufficient (Impaired image quality precludes adequate diagnostic assessment because of severe image noise or insufficient contrast enhancement; need to repeat the examination); 2=Adequate (Image quality in terms of noise and contrast enhancement does not interfere with sufficient diagnostic assessment; delineation of small structures may be suboptimal); or 3=Good (Absent or minimal image noise and good contrast enhancement allow adequate diagnostic assessment with clear delineation of even small structures).", 
            "measure": "Diagnostic Quality", 
            "safety_issue": "No", 
            "time_frame": "Immediately after the single injection of contrast agent"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01737333"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Bracco Diagnostics, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bracco Diagnostics, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}